======= SETDB2 =======
== Gene Information ==
* **Official Symbol**: SETDB2
* **Official Name**: SET domain bifurcated histone lysine methyltransferase 2
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=83852|83852]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q96T68|Q96T68]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=SETDB2&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SETDB2|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/607865|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Histone methyltransferase involved in left-right axis specification in early development and mitosis. Specifically trimethylates 'Lys-9' of histone H3 (H3K9me3). H3K9me3 is a specific tag for epigenetic transcriptional repression that recruits HP1 (CBX1, CBX3 and/or CBX5) proteins to methylated histones. Contributes to H3K9me3 in both the interspersed repetitive elements and centromere-associated repeats. Plays a role in chromosome condensation and segregation during mitosis. {ECO:0000269|PubMed:20404330}.
|MBD|
|SET|
|Pre-SET|
|histone methyltransferase activity (H3-K9 specific)|
|left/right axis specification|
|histone H3-K9 methylation|
|histone H3-K9 modification|
|left/right pattern formation|
|heart looping|
|embryonic heart tube morphogenesis|
|determination of heart left/right asymmetry|
|histone lysine methylation|
|embryonic heart tube development|
|axis specification|
|peptidyl-lysine methylation|
|histone methylation|
|determination of left/right symmetry|
|determination of bilateral symmetry|
|chromosome|
|specification of symmetry|
|protein alkylation|
|protein methylation|
|heart morphogenesis|
|macromolecule methylation|
|chromosome segregation|
|embryonic organ morphogenesis|
|epithelial tube morphogenesis|
|methylation|
|peptidyl-lysine modification|
|regionalization|
|histone modification|
|covalent chromatin modification|
|morphogenesis of an epithelium|
|embryonic organ development|
|pattern specification process|
|cell division|
|heart development|
|tissue morphogenesis|
|embryonic morphogenesis|
|tube morphogenesis|
|mitotic cell cycle|
|chromatin organization|
|zinc ion binding|
|tube development|
|circulatory system development|
|peptidyl-amino acid modification|
|animal organ morphogenesis|
|embryo development|
|chromosome organization|
|epithelium development|
|negative regulation of transcription, DNA-templated|
|negative regulation of nucleic acid-templated transcription|
|negative regulation of RNA biosynthetic process|
|negative regulation of RNA metabolic process|
|cell cycle|
|negative regulation of cellular macromolecule biosynthetic process|
|negative regulation of nucleobase-containing compound metabolic process|
|DNA binding|
|negative regulation of macromolecule biosynthetic process|
|negative regulation of cellular biosynthetic process|
|negative regulation of biosynthetic process|
|negative regulation of gene expression|
|tissue development|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp289|Hydroxyurea 15μM R06 exp289]]|-1.88|
|[[:results:exp3|Actinomycin-D 0.001μM R00 exp3]]|1.82|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 1/726
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/25|
|breast|0/33|
|central nervous system|1/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/15|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/14|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/7|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 17217
* **Expression level (log2 read counts)**: 5.74
{{:chemogenomics:nalm6 dist.png?nolink |}}